QYUNS-B

02509
14.6001.39% ( +0.200 )
Delay Closed: Nov 17, 16:08:15

Valuation

Current ValuationThe current P/E ratio is 5.19, within the reasonable range, cheaper than 62.45% of the time in the past 1 years, and the industry ranks 6/78, the industry Median -4.90.

5.19xP/E
Stock priceHK$14.60Earnings per shareHK$2.81

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0150300450600

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09995HKREMEGEN
4.66x512.28%HK$35.48B
01530HK3SBIO
3.66x71.78%HK$34.84B
09969HKINNOCARE
12.35x13.45%HK$19.60B
02142HKHBM HOLDINGS-B
13.25x8.46%HK$8.78B
02509HKQYUNS-B
5.19x23.95%HK$3.26B
01167HKJACOBIO-B
5.38x--HK$3.18B
06998HKEDDING GENOR
12.48x--HK$3.14B
02197HKCLOVER BIO-B
2.19x--HK$2.15B
01061HKESSEX BIO-TECH
4.13x1.60%HK$1.10B
02566HKJIUYUAN GENE
6.13x--HK$983.91M
00690HKUNI-BIO GROUP
7.63x--HK$370.22M
08158HKCRMI
2.62x--HK$72.11M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.